The mouth and palliative care

American Journal of Hospice and Palliative Medicine

Volumn 17, Issue 2, 2000, Pages 118-124

  Sweeney, M Petrina ^a,b   Bagg, Jeremy ^a  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b Dykebar Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; INFECTION CONTROL; METHODOLOGY; MOUTH DISEASE; MOUTH HYGIENE; MOUTH MUCOSA; REVIEW; STOMATITIS; TERMINAL CARE; THRUSH; VIRUS INFECTION; XEROSTOMIA;

CANDIDIASIS, ORAL; HUMANS; INFECTION CONTROL; MOUTH DISEASES; MOUTH MUCOSA; ORAL HYGIENE; STOMATITIS; TERMINAL CARE; VIRUS DISEASES; XEROSTOMIA;

EID: 0034158417     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/104990910001700212     Document Type: Article

References (66)

1. Pople J, Oliver D: Oral thrush in hospice patients. Nursing Times. 1986; 82: 34-35.
2. Clarke JGM, Wilson J, Von Haacke NP, et al.: Oral candidiasis in terminal illness. Health Bulletin. 1987; 45: 268-271.
3. De Conno F, Ripamonti C, Sbannnotto A, et al.: Oral complications in patients with advanced cancer. J Pall Care. 1989; 5: 7-15.
4. Jobbins J, Bagg J, Addy M, et al.: Oral and dental disease in terminally ill cancer patients. Brit Med J. 1992; 304: 1612.
5. Aldred MJ, Addy M, Bagg J, et al.: Oral health in the terminally ill: A cross-sectional pilot survey. Spec Care Dent. 1991; 11: 59-62.
6. Sweeney MP, Bagg J, Baxter WP, et al.: Oral disease in terminally ill patients with xerostomia. Oral Oncol (Eur J Cancer, Part B). 1998; 34: 123-126.
7. Gordon SR, Berkey DB, Call RL: Dental need among hospice patients in Colorado: A pilot study. Gerodontics. 1985; 1: 125-129
8. Sweeney MP, Bagg J, Doig P, et al.: Provision of mouth care by nursing staff for Scottish cancer patients: current status and the role of training. Nursing Times Res. 1996: 1: 389-395.
9. Sreebny LM, Valdini A: Xerostomia'A neglected symptom. Arch Internal Med. 1987; 147: 1333-1337.
10. Fox P, Van Der Ven PF, Sonies B, et al.: Xerostomia: Evaluation of a symptom with increasing significance. J Am Dent Assoc. 1985; 110: 519-525.
11. Crockett DN: Xerostomia: The missing diagnosis. Australian Dent J. 1993; 38: 114-118.
12. Fox PG, Busch K, Baum BJ: Subjective reports of xerostomia and measures of salivary gland performance. J Am Dent Assoc. 1987; 115: 581-584.
13. Finlay IG: Oral symptoms and Candida in the terminally ill. Brit Med J. 1986; 292: 592-593.
14. Bagg J, Sweeney MP, Harvey Wood K, et al.: Possible role of Staphylococcus aureus in severe oral mucositis among elderly dehydrated patients. Microb Ecol Health and Disease. 1995; 8: 51-56.
15. Jobbins J, Bagg J, Parsons K, et al.: Oral carriage of yeasts, coliforms and staphylococci in patients with advanced malignant disease. J Oral Pathol Med. 1992; 21: 305-308.
16. Gibson J, Beeley JA: Natural and synthetic saliva: A stimulating subject. Biotechnol Genetic Eng Rev. 1994; 12: 40-61.
17. Mandel ID: The role of saliva in maintaining oral homeostasis. J Am Dent Assoc. 1989; 119: 298-304.
18. Hatton MN, Loomis RE, Levine MJ, et al.: Masticatory lubrication. Biochem J. 1988; 230: 817-820.
19. Pollock JJ, Denepitty AL, MacKay BJ, et al.: Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infect Immun. 1984; 44: 702-707.
20. Heineman HS, Greenberg MS: Cell protective effect of human saliva specific for herpes simplex virus. Arch Oral Biol. 1980; 25: 257-261.
21. Helm JF, Dodds WJ, Hogan WJ, et al.: Acid neutralising capacity of human saliva. Gastroenterol. 1982; 83: 69-74.
22. Dawes C: A mathematical model of salivary clearance of sugar from the oral cavity. Caries Res. 1983; 17: 321-334.
23. Sreebny LM, Schwartz SS: A reference guide to drugs and dry mouth. Gerodontology. 1986; 5: 75-99.
24. Sreebny LM et al.: Saliva: Its role in health and disease. Int Dent J. 1992; 42 (suppl 2): 291-304.
25. Davies AN: The management of xerostomia: A review. Eur J Cancer Care. 1997; 6: 209-214.
26. Greenspan JS, Daniels TG: Connective tissue and granulomatous diseases of doubtful origin. In Jones JH, Mason DK (eds.): Oral Manifestations of Systemic Disease, 2nd Ed. London: Baillière Tindall, 1990: 271-299.
27. Fox PC, Van Der Ven PF, Baum BJ, et al.: Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction. Oral Surg, Oral Med, Oral Pathol. 1986; 61: 243-245.
28. Prutting GJ: Pilocarpine nitrate and pyschostimulants. JAMA. 1965; 193: 236-237.
29. Ferguson MM, Hayes P, Highton J, et al.: Pilocarpine oral solution. Brit Dent J. 1991; 170: 251.
30. Davies AN, Daniels C, Pugh R, et al.: A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer. Pall Med. 1998; 12: 105-111.
31. Aagard A, Godiksen S, Tegler PT, et al.: Comparison between new saliva stimulants in patients with dry mouth: a placebo-controlled double-blind crossover study. J Oral Pathol Med. 1992; 21: 376-380.
32. S' Gravenmade EJ, Vissink A: Mucin-containing lozenges in the treatment of intraoral problems associated with Sjögrens syndrome. Oral Surg, Oral Med, Oral Pathol. 1993; 75: 466-471.
33. Levine MJ, Aguirre A, Atton MN, et al.: Artificial salivas: Present and future. J Dental Res. 1987; 66 (spec iss): 693-698.
34. Duxbury AJ, Thakker NS, Wastell DG: A double-blind cross-over trial of a mucin-containing artificial saliva. Brit Dent J. 1989; 166: 115-120.
35. Visch LL, S' Gravenmade EJ, Schaub RMH, et al.: A double-blind crossover trial of CMC and mucin-containing saliva substitutes. Int J Oral Maxillofac Surg. 1986; 15: 395-400.
36. Sweeney MP, Bagg J, Baxter WP, et al.: Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Pall Med. 1997; 11: 225-232.
37. Jobbins J, Addy M, Bagg J, et al.: A clinical trial of chlorhexidine oral spray in terminally ill cancer patients. Pall Med. 1992; 6: 299-307.
38. Beeley JA: Fascinating families of proteins: Electrophoresis of human saliva. Biochem Soc Trans. 1993; 21: 133-138.
39. Van Steenberghe D, Van Den Eynde E, Jacobs R, et al.: Effect of a lactoperoxidase-containing toothpaste in radiation-induced xerostomia. Int Dent J. 1994; 44: 133-138.
40. Regelink, Vissink A, Reintsema H, et al.: Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int. 1998; 29: 383-388.
41. Arendorf TM, Walker DM: Oral candidal populations in health and disease. Brit Dent J. 1979; 147: 267-272.
42. Samaranayake LP, Lamey PJ: Oral candidosis 1: Clinicopathological aspects. Dental Update. 1988; 15: 227-231.
43. Wray D, Bagg J: Pocket Reference to Oral Candidosis. London: Science Press, 1998.
44. MacFarlane TW, Helnarska S: The microbiology of angular cheilitis. Brit Dent J. 1976; 140: 403-406.
45. Warnock DW: Azole drug resistance in Candida species. J Med Microbiol. 1992; 37: 225-226.
46. Cartledge JD, Midgley J, Gazzard BG: Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis. AIDS. 1997; 11: 1839-1844.
47. Blatchford NR: Treatment of oral candidosis with itraconazole: A review. J Am Acad Dermatol. 1990; 23: 565-567.
48. Graybill JR, Vazquez J, Darrouiche RO, et al.: Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients. Am J Med. 1998; 104: 33-39.
49. Ball K, Sweeney MP, Baxter WP, et al.: Fluconazole sensitivities of Candida species isolated from the mouths of terminally ill cancer patients. American Journal of Hospice & Palliative Care. 1998; 15(6): 315-319.
50. Sullivan DJ, Westerneng TJ, Haynes KA, et al.: Candida dubliniensis sp. nov.: Phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology. 1995; 141: 1507-1521.
51. Coleman DC, Sullivan DJ, Bennett DE, et al.: Candidiasis: The emergence of a novel species, Candida dubliniensis. AIDS. 1997; 11: 557-567.
52. Sullivan D, Coleman D. Candida dubliniensis: Characteristics and identification. J Clin Microbiol. 1998; 36: 329-334.
53. Kameyama T, Sujaku C, Yamamoto S, et al.: Shedding of herpes simplex virus type 1 into saliva. J Oral Pathol. 1988; 17: 478-481.
54. Barrett AP: A long-term prospective clinical study of orofacial herpes simplex-virus infection in acute leukemia. Oral Surg, Oral Med, Oral Pathol. 1986; 61: 149-152.
55. Barrett AP: A long-term prospective clinical study of oral complications during conventional chemotherapy for acute leukemia. Oral Surg, Oral Med, Oral Pathol. 1987; 63: 313-316.
56. Dreizen S, McCredie KB, Keating MJ, et al.: Oral infections associated with chemotherapy in adults with acute leukemia. Post-grad Med. 1982; 71: 33-46.
57. Rand HR, Kramer B, Johnson AC: Cancer chemotherapy and associated symptomatic stomatitis and the role of herpes simplex virus. Cancer. 1982; 50: 1262-1265.
58. Bagg J, Mannings A, Munro J, et al.: Rapid diagnosis of oral herpes simplex or zoster virus infections by immunofluorescence: Comparison with Tzanck cell preparations and viral culture. Brit Dent J. 1989; 167: 235-238.
59. Nguyen AMH: Dental management of patients who receive chemo- and radiation therapy. Gen Dent. 1992; 40: 305-311.
60. Childers NK, Stinnett GA, Wheeler RDM, et al.: Oral complications in children with cancer. Oral Surg, Oral Med, Oral Pathol. 1993; 73: 41-47.
61. Landsaat PM., Van Der Lilie H, Bongaerts G, et al.: Fusobacterium nucleatum, a new invasive pathogen in neutropenic patients? Scand J Infect Disease. 1995; 27: 83-84.
62. Zerbe MB, Parkerson SG, Ortlieb ML, et al.: Relationships between oral mucositis and treatment variables in bone marrow transplant patients. Cancer Nursing. 1992; 15: 196-205.
63. Twycross RG, Lack SA: Taste change. In Twycross RG, Lack SA (eds.): Control of Alimentary Symptoms in Far Advanced Cancer. Edinburgh: Churchill Livingstone, 1986: 57-65.
64. Cohen IK, Schecter PJ, Henkin RI: Hypogeusia, anorexia and altered zinc metabolism following thermal burns. JAMA. 1973; 223: 914-916.
65. Davies KJT, Musa M, Dormandy TL: Measurements of plasma zinc pair II in malignant disease. J Clin Pathol. 1986; 21: 359-365.
66. Willoughby JM: Drug-induced abnormalities of taste sensation. Adv Drug Reaction Bulletin. 1983; 100: 368-371.